NO20055497L - Biologisk aktive oljer - Google Patents

Biologisk aktive oljer

Info

Publication number
NO20055497L
NO20055497L NO20055497A NO20055497A NO20055497L NO 20055497 L NO20055497 L NO 20055497L NO 20055497 A NO20055497 A NO 20055497A NO 20055497 A NO20055497 A NO 20055497A NO 20055497 L NO20055497 L NO 20055497L
Authority
NO
Norway
Prior art keywords
biologically active
substrate
oils
active oils
lipid
Prior art date
Application number
NO20055497A
Other languages
English (en)
Other versions
NO20055497D0 (no
Inventor
Athol Gillies Turner
Original Assignee
Athol Gillies Turner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Athol Gillies Turner filed Critical Athol Gillies Turner
Publication of NO20055497D0 publication Critical patent/NO20055497D0/no
Publication of NO20055497L publication Critical patent/NO20055497L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/02—Pretreatment
    • C11B1/025—Pretreatment by enzymes or microorganisms, living or dead
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/06—Production of fats or fatty oils from raw materials by pressing
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/10—Production of fats or fatty oils from raw materials by extracting
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/10—Production of fats or fatty oils from raw materials by extracting
    • C11B1/102—Production of fats or fatty oils from raw materials by extracting in counter-current; utilisation of an equipment wherein the material is conveyed by a screw
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/12—Production of fats or fatty oils from raw materials by melting out
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00—Refining fats or fatty oils
    • C11B3/006—Refining fats or fatty oils by extraction
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00—Refining fats or fatty oils
    • C11B3/008—Refining fats or fatty oils by filtration, e.g. including ultra filtration, dialysis
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00—Refining fats or fatty oils
    • C11B3/12—Refining fats or fatty oils by distillation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)

Abstract

Fremgangsmåte for fremstilling av fett eller oljer, samt deres ekstrakter, irmeholdende biologisk aktive kjemiske forbindelser fiia et lipidsubstrat, der fremgangsmåten omfatter: a) å inokulere et lipidsubstrat med lipolytiske enzymer derivert fra sopp, b) å inkubere det inokulerte subsfratet over en tidsperiode på mellom ca 7 -120 dager ved en temperatur mellom ca 4 - 35°C, ved en fiiktighet mellom ca 75 - 100 %, og c) å bearbeide substratblandingen for å oppnå en biologisk aktiv fett eller olje.
NO20055497A 2003-06-04 2005-11-21 Biologisk aktive oljer NO20055497L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003902823A AU2003902823A0 (en) 2003-06-04 2003-06-04 Biologically active oils
PCT/AU2004/000745 WO2004108941A1 (en) 2003-06-04 2004-06-04 Biologically active oils

Publications (2)

Publication Number Publication Date
NO20055497D0 NO20055497D0 (no) 2005-11-21
NO20055497L true NO20055497L (no) 2005-12-27

Family

ID=31953864

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055497A NO20055497L (no) 2003-06-04 2005-11-21 Biologisk aktive oljer

Country Status (9)

Country Link
US (4) US20060183799A1 (no)
EP (1) EP1654375B1 (no)
JP (2) JP2006526392A (no)
AT (1) ATE553207T1 (no)
AU (2) AU2003902823A0 (no)
CA (1) CA2527967A1 (no)
NO (1) NO20055497L (no)
WO (1) WO2004108941A1 (no)
ZA (1) ZA200509540B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8277849B2 (en) 2006-01-19 2012-10-02 Solazyme, Inc. Microalgae-derived compositions for improving the health and appearance of skin
US8298548B2 (en) 2007-07-18 2012-10-30 Solazyme, Inc. Compositions for improving the health and appearance of skin
US8927522B2 (en) 2008-10-14 2015-01-06 Solazyme, Inc. Microalgal polysaccharide compositions
US8557249B2 (en) 2008-11-07 2013-10-15 Solazyme, Inc. Cosmetic compositions comprising microalgal components
WO2014186395A1 (en) 2013-05-15 2014-11-20 Solazyme, Inc. Cosmetic compositions comprising microalgal oil
CN104745288A (zh) * 2015-03-23 2015-07-01 中南林业科技大学 一种红茶油的提取工艺
JP6167267B2 (ja) * 2015-09-18 2017-07-26 株式会社保健科学研究所 皮膚や大腸粘膜の改善剤
US11690825B2 (en) 2016-03-09 2023-07-04 Board Of Regents, The University Of Texas System 20-HETE receptor (GPR75) antagonists and methods of use
CL2019001240A1 (es) 2019-05-06 2020-03-20 Naturalis S A 90% Proceso para la obtención de composiciones biológicamente activas a partir de aceite de emú, composición farmacéutica antiinflamatoria y anti-irritante, y composición farmacéutica regenerativa de la piel
CN110882572B (zh) * 2019-12-08 2021-11-23 怀化盛源油脂有限公司 一种食用油榨油过滤设备
EP4256068A1 (en) * 2020-12-04 2023-10-11 Evonik Operations GmbH Enzyme based production of specialized pro-resolving mediators (spms) via docosahexaenoic acid (dha) and eicosapentaenoic acid (epa)
CN113440618A (zh) * 2021-07-06 2021-09-28 朱景平 一种透皮基质及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485173A (en) * 1981-01-19 1984-11-27 Cpc International Inc. Preparation of fats and oils
JPS59141515A (ja) 1983-02-02 1984-08-14 Suntory Ltd 発酵養毛化粧料の製造方法
JPS6451091A (en) * 1987-08-20 1989-02-27 Nippon Oils & Fats Co Ltd Production of diacylglycerol rich in polyfunctional unsaturated fatty acid
JPH03206891A (ja) * 1990-01-05 1991-09-10 Nippon Oil & Fats Co Ltd 高度不飽和脂肪酸の分取方法
US5431924A (en) * 1990-11-14 1995-07-11 Emu Products Western Australia Pty. Ltd. Anti-inflammatory composition derived from emu oil
ES2157898T3 (es) * 1991-01-24 2001-09-01 Martek Corp Aceites microbianos y usos de los mismos.
JP3280457B2 (ja) * 1993-03-04 2002-05-13 太陽化学株式会社 卵黄油モノグリセリドの製造方法
GB2293547A (en) 1994-09-27 1996-04-03 Joan Louise Hibberd Compositions containing tea tree oil
JP3689443B2 (ja) * 1994-12-16 2005-08-31 大阪市 高度不飽和脂肪酸含有グリセリドの製造方法
US5744128A (en) * 1995-05-03 1998-04-28 Holick; Michael F. Use of emu oil for stimulating skin and hair growth
US5834027A (en) * 1996-04-03 1998-11-10 Cardinale Fezler; Donna L. Injection of rhea and ostrich oils in animals
AU745551B2 (en) * 1997-03-27 2002-03-21 Bristol-Myers Squibb Company Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
JPH11113536A (ja) * 1997-10-13 1999-04-27 Seiji Toyama 殻付き加工卵及びその製造方法
JPH11221049A (ja) * 1998-02-06 1999-08-17 Asahi Denka Kogyo Kk 酵素処理卵黄の製造方法
AUPS082102A0 (en) * 2002-03-01 2002-03-21 Women's And Children's Hospital Therapeutic properties of oils

Also Published As

Publication number Publication date
US20060183799A1 (en) 2006-08-17
US8039512B2 (en) 2011-10-18
EP1654375A4 (en) 2008-11-12
ATE553207T1 (de) 2012-04-15
US20090048338A1 (en) 2009-02-19
US8329748B2 (en) 2012-12-11
US8629181B2 (en) 2014-01-14
EP1654375A1 (en) 2006-05-10
JP2006526392A (ja) 2006-11-24
NO20055497D0 (no) 2005-11-21
US20120238625A1 (en) 2012-09-20
ZA200509540B (en) 2006-12-27
WO2004108941A8 (en) 2005-01-27
US20130064808A1 (en) 2013-03-14
JP2011067213A (ja) 2011-04-07
AU2003902823A0 (en) 2003-06-26
EP1654375B1 (en) 2012-04-11
WO2004108941A1 (en) 2004-12-16
AU2004245575A1 (en) 2004-12-16
CA2527967A1 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
NO20055497L (no) Biologisk aktive oljer
Burns et al. Reconstitution and biochemical characterization of a new pyridoxal-5 ‘-phosphate biosynthetic pathway
North et al. Microbial pathway for anaerobic 5′-methylthioadenosine metabolism coupled to ethylene formation
DK1784232T3 (da) Biologisk aktive klæbeartikler og fremgangsmåder til fremstilling
MY161546A (en) Novel biopesticide compositions and method for isolation and characterization of same
MA33880B1 (fr) Nouveaux composés efficaces comme inhibiteurs de la xanthine oxydase, leur procédé de préparation et composition pharmaceutique les contenant
DE60238745D1 (de) Glucosamin und verfahren zur herstellung von glucosamin aus mikrobieller biomasse
EA201071067A1 (ru) Микробиологический способ производства спирта
TW200738872A (en) Cell culture vessel and method of manufacturing the same
MX2020010418A (es) Moleculas que tienen utilidad plaguicida, composiciones y proceso para controlar plagas relacionados con estas.
Ribeiro et al. Ultrasound in enzymatic resolution of ethyl 3-hydroxy-3-phenylpropanoate
DE60129805D1 (de) Genetisches testverfahren zur bestimmung des risikos der entwicklung von pouchitis
Koch et al. Medium‐chain fatty acid esters—Optimising their efficacy as anti‐Malassezia agents
Šustr et al. Ecophysiology of the cave isopod Mesoniscus graniger (Frivaldszky, 1865)(Crustacea: Isopoda)
DE60225196D1 (de) Marker-unterstützte rinderauswahl für verbesserte milchzusammensetzung
Chinthalapudi et al. A review of plant-mediated and fertilization-induced shifts in ammonia oxidizers: Implications for nitrogen cycling in agroecosystems
EA200800076A1 (ru) Устройство и способ для ферментативного получения биологически активных соединений
Lo et al. A study of fluorinated β-nitrostyrenes as antimicrobial agents
ATE415470T1 (de) Herstellungsverfahren für iturin a und dessen homologe
ATE491437T1 (de) Formulierungen mit alkylphosphocholinen unter verwendung von neuen negativen ladungsträgern
Sun et al. Properties of aspartate transcarbamylase from TAD1, a psychrophilic bacterial strain isolated from Antarctica
TW200507861A (en) Antiobesity agent using hen-egg antibody against digestive enzyme
MXPA05013649A (es) Fluorbutenos nematicidas que contienen tiazolina.
EP1725669A4 (en) METHOD FOR FORMING STRUCTURAL DEFINED ORGANIC MOLECULES
ATE389657T1 (de) Diaminopyrrolochinazoline als protein-tyrosin- phosphatase-inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application